Smartwatches for Detection of Atrial Fibrillation (AFib) in Secondary Prevention of Cryptogenic Stroke

Recruiting N/A Interventional Study
Ischemic Stroke, Cryptogenic Transient Ischemic Attack Atrial Fibrillation
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
400 (estimated)
Sponsor
Technical University of Munich · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Scientific Background: In secondary prevention of ischemic stroke, detection of atrial fibrillation (AFib) and subsequent anticoagulation therapy reduce the risk of recurrent stroke by approximately 60%. Prolonged electrocardiogram (ECG) monitoring up to 6 months significantly increases detection of AFib in cryptogenic stroke. Wearables like smartwatches have recently been shown to adequately dete…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Implanted Event Recorder with telemedicinal function (e.g., Biotronik BioMon 3m ProMRI HomeMon or similar) * Cryptogenic stroke (within the last six month) after full standard evaluation: * Stroke detected by computed tomography (CT) or magnetic resonance imaging (MRI) that…
Contacts

Silke Wunderlich, Dr.med

0049(0)8941404606

Silke.Wunderlich@tum.de

CONTACT

Horst Penkert, Dr. med.

0049(0)8941404606

h.penkert@tum.de

CONTACT